8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2019 / Double-blind randomized controlled trial
Older adults underwent 12 weeks of aerobic exercise training (AET) while randomized double-blind to placebo (n = 26) or metformin (n = 27). Independent of treatment, AET decreased fat mass, HbA1c, fasting plasma insulin, 24-hr ambulant mean glucose, and glycemic variability. However, metformin attenuated improvements in whole-body insulin sensitivity and VO2 max, and abrogated increases in skeletal muscle mitochondrial respiration. Mitochondrial protein synthesis rates were not different between treatments.
Konopka AR, Laurin JL, Schoenberg HM, et al. Aging Cell, 2019. PMID 30548390
2019 / Three-group randomized crossover trial
Researchers evaluated the acute effects of two energy- and macronutrient-matched meals—a vegan meal with tofu (V-meal) versus a processed-meat and cheese meal (M-meal)—in men with type 2 diabetes, obese men, and healthy men (n=20 each). Postprandial GLP-1 secretion increased after the V-meal in diabetic men (by 30.5%) and healthy men (by 15.8%), while amylin increased across all groups (diabetic by 15.7%, obese by 11.5%, healthy by 13.8%). Postprandial PYY increased significantly only in healthy men (by 18.9%). Satiety was higher after the V-meal in all groups: by 9% in diabetic, 18.7% in obese, and 25% in healthy men.
Klementova M, Thieme L, Haluzik M, et al. Nutrients, 2019. PMID 30642053
2019 / Single-blinded randomized controlled trial
In a 12-week single-blinded trial, 77 constipated patients with type 2 diabetes received cookies containing 10 g flaxseed, 10 g psyllium, or placebo twice daily. Compared to placebo, both flaxseed and psyllium groups showed significant improvements from baseline in constipation symptoms (P = 0.002), stool consistency (P < 0.001), weight (P < 0.001), BMI (P < 0.001), fasting plasma glucose (P = 0.004), cholesterol (P = 0.010), LDL cholesterol (P = 0.031), and cholesterol/HDL cholesterol ratio (P = 0.019). Flaxseed appeared superior to psyllium for improving these markers, and no adverse effects were observed.
Soltanian N, Janghorbani M Clin Nutr ESPEN, 2019. PMID 30661699
2019 / Randomized crossover trial
In a randomized crossover study of obese adults with type 2 diabetes, acute raspberry intake lowered postprandial serum glucose at two and four hours and decreased IL-6 and hsTNF-alpha at four hours (p < 0.05). Following four weeks of daily supplementation, IL-6 and hsTNF-alpha remained significantly reduced compared to control periods (p < 0.05). The intervention did not alter fasting blood sugar, blood lipids, C-reactive protein, or vascular elasticity.
Schell J, Betts NM, Lyons TJ, et al. Ann Nutr Metab, 2019. PMID 30763939
2019 / Randomized crossover trial
In a randomized crossover trial of 20 participants with type 2 diabetes, researchers compared postprandial responses to an energy- and macronutrient-matched standard meat meal versus a vegan meal. Postprandial glucose responses were similar between meals (p = 0.64). However, the vegan meal increased stimulated secretion of insulin (by 30.5%), C-peptide (by 7.1%), amylin (by 15.7%), and GLP-1 (by 19.2%, all p < 0.001), while GIP decreased by -9.4% (p = 0.02). Parameters of beta-cell function also increased after the vegan meal.
Kahleova H, Tura A, Klementova M, et al. Nutrients, 2019. PMID 30813546
2019 / Cross-sectional comparison and short-term dietary intervention
Researchers studied dietary methionine restriction in mice and evaluated circulating FGF21 levels in humans following different diets. In humans, plasma FGF21 levels were markedly higher in vegans compared with omnivores, and circulating FGF21 increased significantly in omnivores after 4 days on a vegetarian diet. In NZO mice, a 9-week methionine-restricted diet elevated plasma FGF21, increased insulin sensitivity, raised energy expenditure, and prevented hyperglycemia without altering food intake or fat mass.
Castaño-Martinez T, Schumacher F, Schumacher S, et al. FASEB J, 2019. PMID 30841758
2019 / Randomized controlled trial
Thirty-four males with type 2 diabetes were randomized to a resistance training group (RTG, n=12), an aerobic training group (ATG, n=11), or a control group (n=11) for 8 weeks. Both ATG and RTG significantly decreased serum fetuin-A and fetuin-B (p < 0.05) and increased FGF-21 (p < 0.05). Compared to ATG, the RTG showed a greater decrease in fetuin-A (-18.3% vs. -7.9%) and fetuin-B (-29.2% vs. -11.45%), and a lower increase in FGF-21 (42.2% vs. 25.1%), respectively.
Keihanian A, Arazi H, Kargarfard M Physiol Int, 2019. PMID 30888221
2019 / Randomized crossover clinical trial
In a randomized crossover trial, 49 prediabetic subjects consumed an isocaloric control diet or a pistachio-supplemented diet (including 57 g pistachios/d) for 4 months each, separated by a 2-week washout. Compared with the control diet, the pistachio diet reduced oxidative damage to DNA (mean: -3.5%; 95% CI: -8.07%, 1.05%; P = 0.009). It also significantly upregulated expression of TERT (164%, P = 0.043) and WRAP53 (53%, P = 0.001). Changes in TERT expression were negatively correlated with changes in fasting plasma glucose and HOMA-IR.
Canudas S, Hernández-Alonso P, Galié S, et al. Am J Clin Nutr, 2019. PMID 31051499
2019 / Randomized, parallel, controlled trial
Sixty-six patients with NAFLD were randomly assigned to a 500-calorie deficit diet either with or without 240 ml/day of soy milk for 8 weeks. Compared to the control group, the soy milk group showed significantly greater reductions in serum insulin (-3.44 ± 5.02 vs. -1.09 ± 3.77 μIU/ml, P = 0.04), HOMA-IR (-0.45 ± 0.64 vs -0.14 ± 0.47, P = 0.03), systolic BP (-3.81 ± 4.15 vs -1.48 ± 2.93 mmHg, P = 0.01), and diastolic BP (-2.39 ± 2.80 vs. -0.94 ± 2.76 mmHg, P = 0.04), plus a significant increase in QUICKI (0.02 ± 0.032 vs. 0.008 ± 0.018, P = 0.04). Changes in fasting blood sugar, HOMA-β%, fibrinogen, and malondialdehyde did not differ significantly between groups.
Maleki Z, Jazayeri S, Eslami O, et al. Complement Ther Med, 2019. PMID 31126574
2019 / Randomized controlled trial
The Women's Health Initiative Dietary Modification trial randomized 48,835 postmenopausal women to either a low-fat dietary pattern intervention (reducing fat to 20% of energy and increasing vegetables, fruit, and grains) or a usual-diet comparison group. Time-to-outcome analyses showed no significant differences for invasive breast cancer, colorectal cancer, or coronary heart disease (CHD) over an 8.5-year median intervention or longer-term follow-up. However, over a 19.6-year median follow-up, the intervention group had significantly lower hazards for breast cancer followed by death (HR 0.84; 95% CI: 0.74, 0.96) and diabetes requiring insulin (HR 0.87; 95% CI: 0.77, 0.98), along with other benefits related to breast cancer, CHD, and diabetes without adverse effects.
Prentice RL, Aragaki AK, Howard BV, et al. J Nutr, 2019. PMID 31175807
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2019 / Randomized double-blind placebo-controlled trial
In a randomized, double-blind trial, patients with type 2 diabetes and CVD received 360 µg/day menaquinone-7 (MK-7, n=35) or placebo (n=33) for 6 months. Target-to-background ratio (TBR) on 18F-NaF PET scans tended to increase in the MK-7 group compared to placebo (0.25; 95% CI: -0.02, 0.51; P = 0.06), but the change was not significant. Log-transformed CT calcification mass did not significantly differ between groups (0.50; 95% CI: -0.23, 1.36; P = 0.18). MK-7 supplementation significantly decreased dp-ucMGP compared with placebo (-205.6 pmol/L; 95% CI: -255.8, -155.3 pmol/L), and no adverse events occurred.
Zwakenberg SR, de Jong PA, Bartstra JW, et al. Am J Clin Nutr, 2019. PMID 31387121
2019 / 12-week randomized, double-blind, placebo-controlled parallel-group trial
A 12-week randomized, double-blind, placebo-controlled trial evaluated the effects of nicotinamide riboside (NR; 1000 mg twice daily, n = 20) versus placebo (n = 20) in 40 males with obesity and insulin resistance. Supplementation with NR did not affect fasting or postchallenge levels of glucose, insulin, C-peptide, glucagon, GLP-1, or GIP, and β-cell function did not respond to the intervention. Furthermore, no changes in circulating adipsin or bile acids were observed.
Dollerup OL, Trammell SAJ, Hartmann B, et al. J Clin Endocrinol Metab, 2019. PMID 31390002
2019 / Randomized clinical trial
In this randomized clinical trial, 43 patients with type 2 diabetes and chronic periodontitis were randomly allocated to receive resveratrol supplements or placebo for 4 weeks alongside non-surgical periodontal therapy. In the intervention group, the mean serum level of IL6 decreased significantly post-intervention from 2.19 ± 1.09 to 1.58 ± 1.06 (P = 0.039). However, no significant differences were observed between the intervention and control groups post-intervention for IL6, TNFα, TAC, or CAL.
Javid AZ, Hormoznejad R, Yousefimanesh HA, et al. Diabetes Metab Syndr, 2019. PMID 31405706
2019 / Randomized crossover trial
In a randomized crossover study, 24 healthy adult males consumed a high-fat breakfast with or without 50 g of freeze-dried mango pulp. At 1 hour post-meal, mango consumption resulted in significantly lower glucose (95.8 ± 4.4 mg/dL vs. 104.8 ± 5.4 mg/dL; P = .002) and higher HDL-C (58.4 ± 2.7 mg/dL vs. 55.2 ± 2.3 mg/dL; P = .01). However, no significant meal × time interactions were observed for triglycerides (P = .88), inflammatory markers (C-reactive protein, P = .17; interleukin-6, P = .30), or antioxidant enzymes (superoxide dismutase, P = .77; glutathione peroxidase, P = .36; catalase, P = .32).
O'Hara C, Ojo B, Emerson SR, et al. Nutr Metab Insights, 2019. PMID 31452602
2019 / Randomized crossover trial
In a randomized crossover trial of 30 females with elevated fasting glucose and insulin, consuming 250 g of baked then chilled potatoes reduced glucose at 15 and 30 minutes by 4.8% and 9.2%, insulin by 25.8% and 22.6%, and GIP by 41.1% and 37.6% compared to boiled potatoes. Insulin and GIP areas under the curve were significantly decreased. Glucose area under the curve, GLP-1, peptide YY, and satiety did not differ.
Patterson MA, Fong JN, Maiya M, et al. Nutrients, 2019. PMID 31484331
2019 / Case report
A 67-year-old female with type 2 diabetes and sepsis developed severe insulin resistance requiring >200 units of insulin per day in the ICU. She received a 2-day modified hypocaloric (700 kcal), low-fat, plant-based diet containing 180 g whole-grain oats and 60 g vegetables administered enterally. Glycaemic control improved significantly, and a significant reduction in total daily insulin requirements was observed during and after the intervention.
Storz MA, Helle P Complement Ther Med, 2019. PMID 31519290
2018 / Randomized crossover trial
In a randomized crossover trial with 13 healthy adults, adding two portions of cooked broccoli to mashed potato led to lower early postprandial blood glucose and insulin surges than potato alone. The broccoli-potato combination reduced peak glucose, incremental peak, and 30-minute incremental area under the curve for both markers. However, adding isolated broccoli fibre or cellulose did not alter post-meal curves compared with potato eaten by itself.
Ballance S, Knutsen SH, Fosvold ØW, et al. Eur J Nutr, 2018. PMID 27655525
2018 / Randomized controlled trial
A community pilot trial assigned 32 Latino adults with type 2 diabetes to a control group or an intervention receiving a 5-week education program on a high-fiber, low-fat plant-based diet plus periodic support. From baseline to 6 months, mean A1C fell from 9.57 to 9.49 in the control group and from 8.53 to 7.31 in the experimental group. The intervention group achieved a statistically significant A1C reduction compared to controls (P = .002).
Ramal E, Champlin A, Bahjri K Am J Health Promot, 2018. PMID 28503930
2018 / Randomized controlled pilot trial
Twenty-four obese male veterans were randomized to either a 5:2 intermittent energy-restricted diet or a standard daily energy-restricted diet for 6 months. Mean weight loss was 5.3 ± 3.0 kg (5.5 ± 3.2%) with the 5:2 diet and 5.5 ± 4.3 kg (5.4 ± 4.2%) with standard restriction, with no significant differences between groups for weight or waist reduction. Systolic blood pressure decreased in both groups, but neither regimen significantly shifted diastolic pressure, fasting glucose, or blood lipids.
Conley M, Le Fevre L, Haywood C, et al. Nutr Diet, 2018. PMID 28791787
2018 / Randomized crossover trial
During a three-day randomized crossover trial in 21 healthy participants, an isocaloric vegan diet lowered triglycerides, insulin, bile acids, and insulin resistance assessed by HOMA-IR (p < 0.05). It also raised magnesium levels and altered branched-chain amino acid metabolism compared with an omnivorous regimen. Fiber and polyunsaturated fats correlated inversely with triglycerides, insulin, and HOMA-IR.
Draper CF, Vassallo I, Di Cara A, et al. Mol Nutr Food Res, 2018. PMID 29087622
2018 / Randomized crossover trial
In a randomized crossover trial, 30 healthy individuals (15 with a family history of type 2 diabetes) consumed isocaloric high-cholesterol/high-fat (HChF) and low-cholesterol/low-fat (LChF) diets for 14 days each. Shifting from HChF to LChF had no effect on body weight but significantly reduced mean glucose (-5%, P = 0.01) and improved beta cell function, including glucose sensitivity (+17%, P = 0.01), fasting insulin secretion (+20%, P = 0.02), and potentiation (+19%, P = 0.03). Insulin sensitivity improved (+7%, P = 0.048) specifically in offspring of individuals with type 2 diabetes.
Tricò D, Trifirò S, Mengozzi A, et al. J Clin Endocrinol Metab, 2018. PMID 29095990
2018 / Randomized controlled dose-response crossover trial
In a randomized, controlled, dose-response crossover trial, 20 young, healthy Chinese men consumed isocaloric, macronutrient-matched test meals of white rice with three doses of curry made with mixed spices and vegetables. Plasma total GLP-1 concentrations were measured at baseline and for up to 3 hours postprandially. Total AUC of plasma GLP-1 concentrations, adjusted for baseline, increased in a dose-dependent manner: adjusted mean (±SEM) of 10568.3 ± 1267.9 pg ml-1.min for Dose 0 Control, 12391.8 ± 1333.94 pg ml-1.min for Dose 1 Curry, and 13905.1 ± 1267.6 pg ml-1.min for Dose 2 Curry (p = 0.019).
Haldar S, Chia SC, Henry CJ Eur J Clin Nutr, 2018. PMID 29284788
2018 / Randomized controlled trial
In an ancillary randomized controlled trial of 53 healthy nonobese adults, 24 months of caloric restriction decreased body weight by 9 ± 0.5 kg, visceral adipose tissue by 0.5 ± 0.01 kg, and blood pressure (systolic -8 ± 3 mmHg; diastolic -6 ± 2 mmHg) compared to ad libitum eating. Total cholesterol fell by 13.6 ± 5.3 mg/dl, LDL-cholesterol decreased by 12.9 ± 4.4 mg/dl, and estimated 10-year cardiovascular risk dropped by 30%. Insulin resistance initially improved during weight loss, but this change was not maintained during weight maintenance.
Most J, Gilmore LA, Smith SR, et al. Am J Physiol Endocrinol Metab, 2018. PMID 29351490